TANG CAPITAL PARTNERS LP 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Purchase |
2023-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
TANG CAPITAL PARTNERS LP | 3,440,345 9.960% |
243,899 (+7.63%) |
Filing |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
TANG CAPITAL PARTNERS LP | 3,196,446 9.400% |
1,796,446 (+128.32%) |
Filing |
| 2022-05-26 4:00 pm Purchase |
2022-05-16 | 13G | KalVista Pharmaceuticals, Inc. KALV |
TANG CAPITAL PARTNERS LP | 1,400,000 5.700% |
1,400,000 (New Position) |
Filing |